
Doris Makari
Advertisement
Articles by Doris Makari
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Giredestrant/Everolimus for ER+, HER2–, ESR1-Mutated Breast Cancer
2
Who Benefits Most From Perioperative Therapy in High-Risk Prostate Cancer?
3
Cretostimogene Cuts Recurrence Risk in Intermediate-Risk, High-Grade Ta NMIBC
4
Belzutifan Plus Lenvatinib Earns Positive CHMP Opinion in Advanced ccRCC
5

